ArticleJournal of translational medicine2025

Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignancies.

Haolong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.